김태환 교수 연구실
article|
green
·인용수 338
·2019
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Désirée van der Heijde, In-Ho Song, Aileen L. Pangan, Atul Deodhar, Filip Van den Bosch, Walter P. Maksymowych, Tae‐Hwan Kim, Mitsumasa Kishimoto, Andrea Everding, Yunxia Sui, Xin Wang, Alvina D. Chu, Joachim Sieper
IF 88.5The Lancet
키워드
MedicineAnkylosing spondylitisPlaceboContraindicationInternal medicineClinical endpointSpondylitisAdverse effectClinical trialSurgery